(Q40111422)

English

Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Europe PubMed Central

Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

arterial hypertension

0 references

1 reference

based on heuristic

inferred from title

author name string

J H Bauer

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

0 references

publication date

1 August 1984

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

American Journal of Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

77

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

43-51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

2A

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Medical intelligence drug therapy: captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Hemodynamic and volume changes associated with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Comparison of the effects of captopril, diuretic and their combination in low- and normal-renin essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Converting enzyme inhibition with an orally active compound in hypertensive man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Acute and chronic effect of captropril in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Endocrine profile in the long-term phase of converting-enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Endocrine and Cardiovascular Influences of Converting Enzyme Inhibition with SQ 14225 in Hypertensive Patients in the Supine Position and during Head-Up Tilt before and after Sodium Depletion*

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Increase in plasma aldosterone during prolonged captopril treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Antihypertensive Therapy with MK 4211

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effects of the Oral Angiotensin-Converting Enzyme Inhibitor MK-421 in Human Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Temporal enhancement of renin-aldosterone blockade by enalapril, an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Comparative Studies: Enalapril Versus Hydrochlorothiazide as First-Step Therapy for the Treatment of Primary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Diurnal Variation of Plasma Aldosterone, Cortisol and Renin Activity in Supine Man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Renal vascular response to interruption of the renin-angiotensin system in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effect of Captopril on Renal Vascular Tone in Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Clinical use of an orally acting converting enzyme inhibitor: captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Sodium intake and renal responses to captopril in normal man and in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Hypotensive and renal effects of captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effect of captopril on renal function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Increased renal plasma flow in long-term enalapril treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Role of angiotensin II in the physiologic regulation of glomerular filtration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effects of propranolol therapy on renal function and body fluid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Effect of chlorothiazide and sodium on vascular responsiveness to angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2884%2980057-1

7 January 2021

Identifiers

10.1016/S0002-9343(84)80057-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6206722%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40111422&oldid=1986076243"